Tuesday, April 23, 2019

Genetic Screening



Today I received the results of my genetic screening from UCSF. I referenced it briefly in my previous update, but I didn’t go into much detail. So, before I discuss the results, let me talk a little bit about what it is, and what it does.

In essence, cancer is simply a mutation that causes abnormal cell division. The mutant cells lose their cues to stop replicating, and the uncontrolled growth and subsequent spread lead to a plethora of problems for the body. Normally, the body has a self-regulating set of checks and balances that keep this from happening. However, we aren’t machines, and the body does occasionally make mistakes. The more mistakes that are made over the time, the greater the likelihood that something is going to go wrong. This is a big part of why cancer risk is strongly correlated with age – the older you are, the more times your cells replicate, and thus more chances there are for something to go wrong. Think like buying a lottery ticket each time they replicate – the chance of “winning” is extraordinarily small, but the more “tickets” you have, the greater your chance of “winning.” And it’s a pretty crappy prize. That being said, we have also identified certain genes that are somewhat associated with different kinds of cancers. More specifically, mutations in certain genes are known to predispose someone to an increased cancer risk. For example, a gene called KRAS is part of the mechanisms that regulate cell growth, division, and proliferation. When mutated, it doesn’t always control these processes properly, and there is a significantly higher chance that something will go wrong. As a result, mutations in the KRAS gene are often associated with much higher risks of cancer, particularly colorectal, pancreatic, and lung. This is what genetic screening is for. It examines specific genes in a person that are known to be problematic if mutated. But we already know I have cancer, so what’s the point? Well, genes are hereditary. If I have a mutation in a specific gene, that’s evidence that my other family members may be at increased risk as well. This gives them an early warning, and thus extra justification for beginning things such as colonoscopies much earlier than usual. Additionally, certain mutations can affect the efficacy of certain cancer treatments. Going back to KRAS, there are certain colorectal cancer drugs that will only work if the patient does not have a mutation in the gene (KRAS wild type). Therefore, knowing the patient’s genotype can significantly alter treatment options and long term plans. Finally, our understanding of the genetic role in cancer is still extremely limited. This is at least partially due to both our limited understanding of which genes control the process, the multifactorial nature of cancer itself, and the somewhat limited sample pool of cancer patients. Every cancer patient that submits their genetic information gives us one more potential piece of the puzzle. So, that’s an overview (albeit extremely simplified) of genetic testing and its value to a cancer patient. So let’s talk about my test and what it found. My test screened me across 90 different genes that are implicated in cancer, particularly colorectal cancer. The DNA sample was pretty easy to provide – I just had to spit into a vial and ship it back to the testing facility. Saliva contains all of the genetic material necessary for the testing. And the results? All normal. Honestly, this isn’t surprising. To date, known inherited mutations factor into only about 5-10% of cancer diagnoses. The rest are possibly due to environmental factors, random chance, some other undiscovered genetic mutations, or some combination of the above. Like I said, cancer is a complex thing. When you consider how much variation there is in a single cancer type, let alone across every possible cancer that can arise in the body, it’s hardly surprising that we still haven’t found a universal cure. Despite the lack of concrete answers, this is still good news. This means that there is a significantly lower chance that my siblings or parents are at greater risk of cancer. While it is still a good idea for them to get screened earlier than usual, it is much less likely that they’ll also develop colorectal cancer than if a mutation was found. Odds are it stays with me. I get to be the lucky unicorn of the family. So, at least I get to say I aced a test today. Even if it means that the prize for doing so was losing part of my butt. I’ll be back in touch with all of you in a couple of weeks when I next visit UCSF. Have a happy (belated) Easter!

I'm Back, and the Fight Continues (Part 1 of 3)

To those of you still following – hello! I’m still alive and kicking. I know it’s been a looooong time since you’ve heard from me, and that’...